Local view for "http://liddi.stanford.edu/LIDDI:SID2977"

Predicate

Value (sorted: default)

dv:drugbank_vocabulary:ddi-interactor-in

ddir:DDI between amiloride and daclizumab - Event - Rhabdomyolysis. [LIDDI_resource:SID0077_SID2977_EID0003]1 ddir:DDI between amiodarone and daclizumab - Event - Parkinsonism. [LIDDI_resource:SID0084_SID2977_EID4965]2 ddir:DDI between azathioprine and daclizumab - Event - Hypoglycaemia. [LIDDI_resource:SID0128_SID2977_EID0002]3 ddir:DDI between baclofen and daclizumab - Event - Hyperkalaemia. [LIDDI_resource:SID0132_SID2977_EID4971]4 ddir:DDI between bumetanide and daclizumab - Event - Parkinsonism. [LIDDI_resource:SID0185_SID2977_EID4965]5 ddir:DDI between calcitriol and daclizumab - Event - Hypoglycaemia. [LIDDI_resource:SID0199_SID2977_EID0002]6 ddir:DDI between cefotaxime and daclizumab - Event - Hyperkalaemia. [LIDDI_resource:SID0245_SID2977_EID4971]7 ddir:DDI between clotrimazole and daclizumab - Event - Serotonin syndrome. [LIDDI_resource:SID0325_SID2977_EID4964]8 ddir:DDI between clotrimazole and daclizumab - Event - Bradycardia. [LIDDI_resource:SID0325_SID2977_EID4970]9 ddir:DDI between cyclophosphamide and daclizumab - Event - Hypoglycaemia. [LIDDI_resource:SID0358_SID2977_EID0002]10 ddir:DDI between diclofenac and daclizumab - Event - Parkinsonism. [LIDDI_resource:SID0412_SID2977_EID4965]11 ddir:DDI between hydromorphone and daclizumab - Event - Rhabdomyolysis. [LIDDI_resource:SID0431_SID2977_EID0003]12 ddir:DDI between diphenoxylate and daclizumab - Event - Parkinsonism. [LIDDI_resource:SID0446_SID2977_EID4965]13 ddir:DDI between doxycycline and daclizumab - Event - Parkinsonism. [LIDDI_resource:SID0462_SID2977_EID4965]14 ddir:DDI between droperidol and daclizumab - Event - Hyperkalaemia. [LIDDI_resource:SID0464_SID2977_EID4971]15 ddir:DDI between fludrocortisone and daclizumab - Event - Hypoglycaemia. [LIDDI_resource:SID0547_SID2977_EID0002]16 ddir:DDI between ganciclovir and daclizumab - Event - Arrhythmia. [LIDDI_resource:SID0584_SID2977_EID4966]17 ddir:DDI between haloperidol and daclizumab - Event - Serotonin syndrome. [LIDDI_resource:SID0619_SID2977_EID4964]18 ddir:DDI between hydralazine and daclizumab - Event - Bradycardia. [LIDDI_resource:SID0640_SID2977_EID4970]19 ddir:DDI between ifosfamide and daclizumab - Event - Bradycardia. [LIDDI_resource:SID0662_SID2977_EID4970]20 ddir:DDI between ketoconazole and daclizumab - Event - Neutropenia. [LIDDI_resource:SID0722_SID2977_EID4963]21 ddir:DDI between megestrol and daclizumab - Event - Hyperkalaemia. [LIDDI_resource:SID0786_SID2977_EID4971]22 ddir:DDI between midazolam and daclizumab - Event - Hyperkalaemia. [LIDDI_resource:SID0855_SID2977_EID4971]23 ddir:DDI between minoxidil and daclizumab - Event - Serotonin syndrome. [LIDDI_resource:SID0860_SID2977_EID4964]24 ddir:DDI between nitrofurantoin and daclizumab - Event - Neutropenia. [LIDDI_resource:SID0912_SID2977_EID4963]25 ddir:DDI between nortriptyline and daclizumab - Event - Bradycardia. [LIDDI_resource:SID0925_SID2977_EID4970]26 ddir:DDI between nystatin and daclizumab - Event - Arrhythmia. [LIDDI_resource:SID0930_SID2977_EID4966]27 ddir:DDI between pentostatin and daclizumab - Event - Pancytopenia. [LIDDI_resource:SID0990_SID2977_EID4962]28 ddir:DDI between piperacillin and daclizumab - Event - Serotonin syndrome. [LIDDI_resource:SID1046_SID2977_EID4964]29 ddir:DDI between prednisone and daclizumab - Event - Arrhythmia. [LIDDI_resource:SID1092_SID2977_EID4966]30 ddir:DDI between ranitidine and daclizumab - Event - Pancytopenia. [LIDDI_resource:SID1155_SID2977_EID4962]31 ddir:DDI between sulfamethoxazole and daclizumab - Event - Hypoglycaemia. [LIDDI_resource:SID1247_SID2977_EID0002]32 ddir:DDI between tamoxifen and daclizumab - Event - Long QT syndrome. [LIDDI_resource:SID1269_SID2977_EID4959]33 ddir:DDI between theophylline and daclizumab - Event - Neutropenia. [LIDDI_resource:SID1285_SID2977_EID4963]34 ddir:DDI between tramadol and daclizumab - Event - Pancytopenia. [LIDDI_resource:SID1324_SID2977_EID4962]35 ddir:DDI between tramadol and daclizumab - Event - Arrhythmia. [LIDDI_resource:SID1324_SID2977_EID4966]36 ddir:DDI between vinblastine and daclizumab - Event - Hypoglycaemia. [LIDDI_resource:SID1386_SID2977_EID0002]37 ddir:DDI between warfarin and daclizumab - Event - Serotonin syndrome. [LIDDI_resource:SID1397_SID2977_EID4964]38 ddir:DDI between gemcitabine and daclizumab - Event - Hypoglycaemia. [LIDDI_resource:SID1423_SID2977_EID0002]39 ddir:DDI between foscarnet and daclizumab - Event - Hyperkalaemia. [LIDDI_resource:SID2057_SID2977_EID4971]40 ddir:DDI between temozolomide and daclizumab - Event - Arrhythmia. [LIDDI_resource:SID2210_SID2977_EID4966]41 ddir:DDI between terbinafine and daclizumab - Event - Rhabdomyolysis. [LIDDI_resource:SID2213_SID2977_EID0003]42 ddir:DDI between terbinafine and daclizumab - Event - Serotonin syndrome. [LIDDI_resource:SID2213_SID2977_EID4964]43 ddir:DDI between zonisamide and daclizumab - Event - Rhabdomyolysis. [LIDDI_resource:SID2304_SID2977_EID0003]44 ddir:DDI between pantoprazole and daclizumab - Event - Hypoglycaemia. [LIDDI_resource:SID2318_SID2977_EID0002]45 ddir:DDI between fluvastatin and daclizumab - Event - Rhabdomyolysis. [LIDDI_resource:SID2321_SID2977_EID0003]46 ddir:DDI between goserelin and daclizumab - Event - Pancytopenia. [LIDDI_resource:SID2426_SID2977_EID4962]47 ddir:DDI between topotecan and daclizumab - Event - Neutropenia. [LIDDI_resource:SID2504_SID2977_EID4963]48 ddir:DDI between entacapone and daclizumab - Event - Serotonin syndrome. [LIDDI_resource:SID2538_SID2977_EID4964]49 ddir:DDI between entacapone and daclizumab - Event - Hyperkalaemia. [LIDDI_resource:SID2538_SID2977_EID4971]50 ddir:DDI between lamivudine and daclizumab - Event - Bradycardia. [LIDDI_resource:SID2582_SID2977_EID4970]51 ddir:DDI between pemetrexed and daclizumab - Event - Hyperkalaemia. [LIDDI_resource:SID2584_SID2977_EID4971]52 ddir:DDI between troglitazone and daclizumab - Event - Serotonin syndrome. [LIDDI_resource:SID2624_SID2977_EID4964]53 ddir:DDI between anastrozole and daclizumab - Event - Bradycardia. [LIDDI_resource:SID2694_SID2977_EID4970]54 ddir:DDI between voriconazole and daclizumab - Event - Hyperkalaemia. [LIDDI_resource:SID2873_SID2977_EID4971]55 ddir:DDI between moxifloxacin and daclizumab - Event - Bradycardia. [LIDDI_resource:SID2918_SID2977_EID4970]56 ddir:DDI between pregabalin and daclizumab - Event - Neutropenia. [LIDDI_resource:SID2976_SID2977_EID4963]57 ddir:DDI between daclizumab and azathioprine - Event - Hypoglycaemia. [LIDDI_resource:SID2977_SID0128_EID0002]58 ddir:DDI between daclizumab and bumetanide - Event - Parkinsonism. [LIDDI_resource:SID2977_SID0185_EID4965]59 ddir:DDI between daclizumab and cefazolin - Event - Hypoglycaemia. [LIDDI_resource:SID2977_SID0241_EID0002]60 ddir:DDI between daclizumab and cefotaxime - Event - Hyperkalaemia. [LIDDI_resource:SID2977_SID0245_EID4971]61 ddir:DDI between daclizumab and cefuroxime - Event - Neutropenia. [LIDDI_resource:SID2977_SID0253_EID4963]62 ddir:DDI between daclizumab and clonazepam - Event - Pancytopenia. [LIDDI_resource:SID2977_SID0317_EID4962]63 ddir:DDI between daclizumab and clotrimazole - Event - Serotonin syndrome. [LIDDI_resource:SID2977_SID0325_EID4964]64 ddir:DDI between daclizumab and colchicine - Event - Arrhythmia. [LIDDI_resource:SID2977_SID0333_EID4966]65 ddir:DDI between daclizumab and cyclophosphamide - Event - Hypoglycaemia. [LIDDI_resource:SID2977_SID0358_EID0002]66 ddir:DDI between daclizumab and daunorubicin - Event - Rhabdomyolysis. [LIDDI_resource:SID2977_SID0373_EID0003]67 ddir:DDI between daclizumab and hydromorphone - Event - Arrhythmia. [LIDDI_resource:SID2977_SID0431_EID4966]68 ddir:DDI between daclizumab and estradiol - Event - Neutropenia. [LIDDI_resource:SID2977_SID0491_EID4963]69 ddir:DDI between daclizumab and fludrocortisone - Event - Hypoglycaemia. [LIDDI_resource:SID2977_SID0547_EID0002]70 ddir:DDI between daclizumab and ganciclovir - Event - Arrhythmia. [LIDDI_resource:SID2977_SID0584_EID4966]71 ddir:DDI between daclizumab and glucosamine - Event - Rhabdomyolysis. [LIDDI_resource:SID2977_SID0598_EID0003]72 ddir:DDI between daclizumab and glucosamine - Event - Parkinsonism. [LIDDI_resource:SID2977_SID0598_EID4965]73 ddir:DDI between daclizumab and haloperidol - Event - Arrhythmia. [LIDDI_resource:SID2977_SID0619_EID4966]74 ddir:DDI between daclizumab and ibuprofen - Event - Long QT syndrome. [LIDDI_resource:SID2977_SID0658_EID4959]75 ddir:DDI between daclizumab and lidocaine - Event - Hypoglycaemia. [LIDDI_resource:SID2977_SID0742_EID0002]76 ddir:DDI between daclizumab and midazolam - Event - Hyperkalaemia. [LIDDI_resource:SID2977_SID0855_EID4971]77 ddir:DDI between daclizumab and nystatin - Event - Hypoglycaemia. [LIDDI_resource:SID2977_SID0930_EID0002]78 ddir:DDI between daclizumab and piperacillin - Event - Serotonin syndrome. [LIDDI_resource:SID2977_SID1046_EID4964]79 ddir:DDI between daclizumab and propylthiouracil - Event - Hyperkalaemia. [LIDDI_resource:SID2977_SID1124_EID4971]80 ddir:DDI between daclizumab and sulfamethoxazole - Event - Hypoglycaemia. [LIDDI_resource:SID2977_SID1247_EID0002]81 ddir:DDI between daclizumab and tamoxifen - Event - Long QT syndrome. [LIDDI_resource:SID2977_SID1269_EID4959]82 ddir:DDI between daclizumab and theophylline - Event - Neutropenia. [LIDDI_resource:SID2977_SID1285_EID4963]83 ddir:DDI between daclizumab and vinblastine - Event - Hypoglycaemia. [LIDDI_resource:SID2977_SID1386_EID0002]84 ddir:DDI between daclizumab and warfarin - Event - Pancytopenia. [LIDDI_resource:SID2977_SID1397_EID4962]85 ddir:DDI between daclizumab and zidovudine - Event - Hypoglycaemia. [LIDDI_resource:SID2977_SID1407_EID0002]86 ddir:DDI between daclizumab and zidovudine - Event - Hyperkalaemia. [LIDDI_resource:SID2977_SID1407_EID4971]87 ddir:DDI between daclizumab and gemcitabine - Event - Hypoglycaemia. [LIDDI_resource:SID2977_SID1423_EID0002]88 ddir:DDI between daclizumab and azithromycin - Event - Serotonin syndrome. [LIDDI_resource:SID2977_SID1513_EID4964]89 ddir:DDI between daclizumab and cefepime - Event - Hypoglycaemia. [LIDDI_resource:SID2977_SID1603_EID0002]90 ddir:DDI between daclizumab and cefepime - Event - Bradycardia. [LIDDI_resource:SID2977_SID1603_EID4970]91 ddir:DDI between daclizumab and itraconazole - Event - Rhabdomyolysis. [LIDDI_resource:SID2977_SID1877_EID0003]92 ddir:DDI between daclizumab and foscarnet - Event - Neutropenia. [LIDDI_resource:SID2977_SID2057_EID4963]93 ddir:DDI between daclizumab and tazobactam - Event - Pancytopenia. [LIDDI_resource:SID2977_SID2205_EID4962]94 ddir:DDI between daclizumab and temozolomide - Event - Hypoglycaemia. [LIDDI_resource:SID2977_SID2210_EID0002]95 ddir:DDI between daclizumab and terbinafine - Event - Rhabdomyolysis. [LIDDI_resource:SID2977_SID2213_EID0003]96 ddir:DDI between daclizumab and terbinafine - Event - Serotonin syndrome. [LIDDI_resource:SID2977_SID2213_EID4964]97 ddir:DDI between daclizumab and zonisamide - Event - Rhabdomyolysis. [LIDDI_resource:SID2977_SID2304_EID0003]98 ddir:DDI between daclizumab and fluvastatin - Event - Rhabdomyolysis. [LIDDI_resource:SID2977_SID2321_EID0003]99 ddir:DDI between daclizumab and latanoprost - Event - Rhabdomyolysis. [LIDDI_resource:SID2977_SID2371_EID0003]100 ddir:DDI between daclizumab and latanoprost - Event - Serotonin syndrome. [LIDDI_resource:SID2977_SID2371_EID4964]101 ddir:DDI between daclizumab and goserelin - Event - Long QT syndrome. [LIDDI_resource:SID2977_SID2426_EID4959]102 ddir:DDI between daclizumab and topotecan - Event - Neutropenia. [LIDDI_resource:SID2977_SID2504_EID4963]103 ddir:DDI between daclizumab and entacapone - Event - Serotonin syndrome. [LIDDI_resource:SID2977_SID2538_EID4964]104 ddir:DDI between daclizumab and entacapone - Event - Hyperkalaemia. [LIDDI_resource:SID2977_SID2538_EID4971]105 ddir:DDI between daclizumab and troglitazone - Event - Serotonin syndrome. [LIDDI_resource:SID2977_SID2624_EID4964]106 ddir:DDI between daclizumab and repaglinide - Event - Neutropenia. [LIDDI_resource:SID2977_SID2632_EID4963]107 ddir:DDI between daclizumab and paricalcitol - Event - Arrhythmia. [LIDDI_resource:SID2977_SID2642_EID4966]108 ddir:DDI between daclizumab and tamsulosin - Event - Hypoglycaemia. [LIDDI_resource:SID2977_SID2654_EID0002]109 ddir:DDI between daclizumab and atorvastatin - Event - Rhabdomyolysis. [LIDDI_resource:SID2977_SID2682_EID0003]110 ddir:DDI between daclizumab and atorvastatin - Event - Long QT syndrome. [LIDDI_resource:SID2977_SID2682_EID4959]111 ddir:DDI between daclizumab and mometasone - Event - Neutropenia. [LIDDI_resource:SID2977_SID2832_EID4963]112 ddir:DDI between daclizumab and rabeprazole - Event - Rhabdomyolysis. [LIDDI_resource:SID2977_SID2853_EID0003]113 ddir:DDI between daclizumab and voriconazole - Event - Hyperkalaemia. [LIDDI_resource:SID2977_SID2873_EID4971]114 ddir:DDI between daclizumab and pregabalin - Event - Neutropenia. [LIDDI_resource:SID2977_SID2976_EID4963]115 ddir:DDI between daclizumab and trastuzumab - Event - Neutropenia. [LIDDI_resource:SID2977_SID3058_EID4963]116 ddir:DDI between daclizumab and nateglinide - Event - Arrhythmia. [LIDDI_resource:SID2977_SID3414_EID4966]117 ddir:DDI between daclizumab and valganciclovir - Event - Hyperkalaemia. [LIDDI_resource:SID2977_SID3421_EID4971]118 ddir:DDI between daclizumab and imatinib - Event - Arrhythmia. [LIDDI_resource:SID2977_SID3431_EID4966]119 ddir:DDI between daclizumab and escitalopram - Event - Hypoglycaemia. [LIDDI_resource:SID2977_SID3823_EID0002]120 ddir:DDI between daclizumab and ezetimibe - Event - Rhabdomyolysis. [LIDDI_resource:SID2977_SID3874_EID0003]121 ddir:DDI between daclizumab and bortezomib - Event - Serotonin syndrome. [LIDDI_resource:SID2977_SID4002_EID4964]122 ddir:DDI between daclizumab and sitagliptin - Event - Neutropenia. [LIDDI_resource:SID2977_SID4107_EID4963]123 ddir:DDI between candesartan and daclizumab - Event - Hypoglycaemia. [LIDDI_resource:SID3007_SID2977_EID0002]124 ddir:DDI between rofecoxib and daclizumab - Event - Long QT syndrome. [LIDDI_resource:SID3077_SID2977_EID4959]125 ddir:DDI between rofecoxib and daclizumab - Event - Parkinsonism. [LIDDI_resource:SID3077_SID2977_EID4965]126 ddir:DDI between valganciclovir and daclizumab - Event - Hyperkalaemia. [LIDDI_resource:SID3421_SID2977_EID4971]127 ddir:DDI between rosuvastatin and daclizumab - Event - Rhabdomyolysis. [LIDDI_resource:SID3546_SID2977_EID0003]128 ddir:DDI between escitalopram and daclizumab - Event - Hypoglycaemia. [LIDDI_resource:SID3823_SID2977_EID0002]129 ddir:DDI between cinacalcet and daclizumab - Event - Hypoglycaemia. [LIDDI_resource:SID4039_SID2977_EID0002]130 ddir:DDI between sitagliptin and daclizumab - Event - Long QT syndrome. [LIDDI_resource:SID4107_SID2977_EID4959]131

Named graphs describing this resource:

The resource does not appear as an object

Context graph